Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04774640 · ClinicalTrials.gov registry record
Development of a NIPTT for Detecting Copy Number Variations
A clinical trial, sponsored by Sequenom.
- Terminated
- Registry status
- 9
- Enrollment target
NCT04774640 is a clinical trial that was terminated before completion, run by Sequenom. The registered enrollment target is 9 participants.
The verdict
NCT04774640 was terminated before completion, sponsored by Sequenom.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
To collect whole blood samples from pregnant women for the purpose of developing, optimizing and evaluating laboratory-developed noninvasive prenatal test (NIPT) for the detection of fetal chromosomal abnormalities of interest defined as microinsertions, microdeletions and other copy number variations (CNVs). The NIPT result will be compared to the test results obtained by microarray analysis of fetal cellular material obtained by amniocentesis or chorionic villus sampling.
Interventions
- DEVICE MaterniT GENOME
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-05-29 |
| Est. Completion | 2018-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04774640
The ClinicalTrials.gov registry entry for NCT04774640 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sequenom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MaterniT GENOME is the first listed.
NCT04774640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04774640 about?
NCT04774640 is a clinical study titled "Development of a NIPTT for Detecting Copy Number Variations". To collect whole blood samples from pregnant women for the purpose of developing, optimizing and evaluating laboratory-developed noninvasive prenatal test (NIPT) for the detection of fetal chromosomal abnormalities of interest defined as microinsertions, microdeletions and other copy number variatio...
What is the current status of trial NCT04774640?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2014-05-29. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT04774640?
The interventions under investigation include: MaterniT GENOME (DEVICE).
Who is sponsoring clinical trial NCT04774640?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.